Company / Current Liabilities
IDEAYA Biosciences, Inc. Current Liabilities History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$58.8M
FY2025
5-year range
$27.1M / $58.8M
FY2021-FY2025
Trend
+27.7%
vs FY2024
Sector context
#132 of 213
Health Care
What the data says
At $59M, IDEAYA Biosciences, Inc.'s current liabilities ranks #82 of 213 in the Health Care sector. Increased from $27M to $59M over the past 2 years.
Based on SEC 10-K filings.
$59M in FY2025 with a 5-year CAGR of +8.8%.
Increased from $27M to $59M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +22.9%
- 5-Year CAGR
- +8.8%
- 10-Year CAGR
- -
Sector benchmark
#82 of 213 in Health CareTop 38% of 213This company $58.8M Sector average $1.6B
▼
-96.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.8%, indicating consistent growth.
- In FY2025, current liabilities increased 27.7% year-over-year.
- Ranks #132 out of 213 companies in the Health Care sector.
- Lowest current liabilities in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $58.8M | +27.7% |
| FY2024 | $46.1M | +70.0% |
| FY2023 | $27.1M | -14.6% |
| FY2022 | $31.7M | -29.8% |
| FY2021 | $45.2M | +16.9% |
| FY2020 | $38.6M | +456.8% |
| FY2019 | $6.9M | +28.2% |
| FY2018 | $5.4M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026